All Type of News
Health insurance expenditures rise 6 % in 2011
Korea's health insurance outlays rose 6 percent on-year in 2011, a state-run agency report said on Mar. 18.
The National Health Insurance Corp. (NHIC) said the total amount spent to cover a variety of checkups and ...
Ildong to conduct clinical trials to develop IMDs
Ildong Pharmaceutical Co. has unveiled its plan to develop seven incrementally modified drugs (IMDs) this year, while undertaking the clinical trials of Cotromvix (clopidogrel + asprin), a dual-purpose drug to treat t...
Dong-A releases new topical medication
Dong-A Pharmaceutical Co. said Monday that it has rolled out Melanosa cream (hydroquinone) as over-the-counter version to alleviate freckles, sun spots large areas of discoloration.
Melanin is the brown pigment fou...
Some leading drugmakers rely on other commodities heavily in 2011 sales
Jeil Pharmaceutical and Yuhan Corporation were shown to excessively depend on multinational companies’ original brands in their sales portion in 2011, it was learned by data released Yakup.com, a pharmaceutical inform...
Kim Won-bae renamed as head of Dong-A
Kim Won-bae, incumbent Dong-A Pharmaceutical Co., was renamed last Friday as its president in the annual shareholders' meeting.
Kim, who served as CEO of Dong-A for almost ten years since March 2003, will serve his...
Park to head Dongwha Pharma
Dongwha Pharmaceutical Co. said last Friday that it has named Park Je-wha, former chief executive of Janssen Korea, as new president.
Park replaced Jo Chang-soo, who is departing the company for personal reasons.
...
On-site inspection team to check GMP related issues
The Korea Food and Drug Administration said recently it will team up to make on-site inspections aimed at checking the overall administration of 50 GMP (Good Manufacturing Practice)-accredited companies as part of its...
DUP expels Rep. Chun Jeon Hae-sook
The main opposition Democratic United Party (DUP) on Thursday revoked two of its candidates for the April 11 legislative election ― incumbent Rep. Jeon Hae-sook and former Rep. Lee Hwa-young.
The Supreme Council de...
Local drug makers to be hit by patent suits
Korean drug firms would face an uphill battle in patent infringement lawsuits as the Korea-U.S. free trade agreement (KORUS FTA) went into effect Thursday, citing the need for effective policy to support them.
Acc...
Civic groups call for post-FTA steps for pharmaceutical companies
Local civic groups called for proper measures to let domestic pharmaceutical firms step up their game with the U.S. counterparts from the Korea-U.S. free trade agreement (KORUS FTA), Thursday.
They said Korean comp...
